Search results
Your search for Supportan returned no results
Showing 151 to 165 of 660 results for supporting
Showing 151 to 165 of 660 results for supporting
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
Recommendation ID NG43/2 Question The role of families in supporting young adults discharged from children's services:- What is the most...
Recommendation ID NG43/3 Question The role of primary care in supporting young people discharged from children's services:- What are the...
Through this featured content, you'll learn how our guidance and advice is supporting effective decision making, for the benefit of...
Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.
Mapping NICE guidelines to the CQC's single assessment framework
This NICE resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Our board has 2 sub-committees: the audit and risk assurance committee and the remuneration committee.
How providers and commissioners can use quality standards to improve the quality of care
COVID-19 rapid guideline: haematopoietic stem cell transplantation (NG164)
The purpose of this guideline is to maximise the safety of patients who need haemopoietic stem cell transplantation and make the best use of NHS resources, while protecting staff from infection.
Show all sections
A timeline showing where in the NICE evaluation process companies will be charged.
settings Providing end of life care and support Planning for the future Supporting parents Services for older people Scenario William,...
guidance in social work: scenarios Families and relationships settings Supporting inter-generational need Involving families in care...
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Padeliporfin for untreated localised prostate cancer (TA546)
Evidence-based recommendations on padeliporfin (Tookad) for untreated, unilateral, low-risk prostate cancer in adults.
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies